European database and biobank for childhood interstitial lung diseases
Orphans Unite: chILD Better Together - European Management Platform for Childhood Interstitial Lung Diseases / chILD-EU - International Register and Biobank for Children´s Interstital Lung Disease
This study is creating a database and biobank to collect information and samples from children with interstitial lung diseases across Europe to improve their treatment and understanding of these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Sex | All |
| Sponsor | Ludwig-Maximilians - University of Munich Academic / other |
| Drugs / interventions | radiation |
| Locations | 3 sites (Hanover, Lower Saxony and 2 other locations) |
| Trial ID | NCT02852928 on ClinicalTrials.gov |
What this trial studies
This project aims to create a comprehensive European database and biobank for children with interstitial lung diseases (chILD). It will involve the collection of clinical data and biological samples from patients across multiple countries, including France, Germany, and the UK. The initiative will also focus on establishing standardized treatment protocols and guidelines through continuous assessment by a panel of experts. Additionally, it seeks to recruit a well-characterized cohort of chILD patients to enhance understanding and management of these conditions.
Who should consider this trial
Good fit: Ideal candidates for this study are children with suspected or confirmed diagnoses of interstitial lung diseases.
Not a fit: Patients with conditions that do not meet the inclusion criteria for interstitial lung diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could significantly improve the diagnosis and treatment of childhood interstitial lung diseases.
How similar studies have performed: Other studies have successfully established similar databases and biobanks, indicating a promising approach for improving patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * all children with suspected or * verified diagnosis of ILD or * masquerading as ILD and * those with rare localized parenchymal lung diseases Exclusion Criteria: * other indication as inclusion criteria
Where this trial is running
Hanover, Lower Saxony and 2 other locations
- Medizinische Hochschule Hannover — Hanover, Lower Saxony, Germany (Recruiting)
- Hacettepe University, Medical Faculty — Ankara, Sihhiye, Turkey (Türkiye) (Recruiting)
- University of Edinburgh — Edinburgh, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Matthias Griese, Prof.
- Email: Matthias.Griese@med.uni-muenchen.de
- Phone: +49/89/440057871
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.